ENZN has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
ENZN has been removed from your Stock Email Alerts list.
|
Ticker![]() | Guru | Date
|
Action |
Impact
![]() |
Price Range (Average)*
![]() |
Current Price | Change from Average![]() |
Comment | Current Shares | |
|---|---|---|---|---|---|---|---|---|---|---|
| ENZN | Charles Brandes | 2013-03-31 | Add | 0.01% | $3.79 - $4.99 ($4.54) | $ 3.17 | -30% | Add 432.17% | 360,865 | |
| ENZN | Charles Brandes | 2012-12-31 | Add | $4.35 - $7 ($6.03) | $ 3.17 | -47% | Add 35.19% | 67,810 | ||
| ENZN | Jean-Marie Eveillard | 2012-12-31 | Sold Out | -0.01% | $4.35 - $7 ($6.03) | $ 3.17 | -47% | Sold Out | 0 | |
| ENZN | Jean-Marie Eveillard | 2012-09-30 | Reduce | -0.02% | $6.42 - $7.17 ($6.8) | $ 3.17 | -53% | Reduce -56.42% | 490,142 | |
| ENZN | Charles Brandes | 2012-06-30 | Add | $5.87 - $7.06 ($6.44) | $ 3.17 | -51% | Add 58.41% | 51,070 | ||
| ENZN | Charles Brandes | 2012-03-31 | Buy | $6.54 - $7.82 ($6.67) | $ 3.17 | -52% | New holding, 32240 sh. | 32,240 | ||
| ENZN | Carl Icahn | 2011-09-30 | Add | 0.07% | $7.24 - $10.37 ($8.8) | $ 3.17 | -64% | Add 25% | 5,904,863 | |
| ENZN | Richard Perry | 2011-09-30 | Sold Out | -0.5937% | $7.24 - $10.37 ($8.8) | $ 3.17 | -64% | Sold Out | 0 | |
| ENZN | George Soros | 2011-06-30 | Sold Out | $9.97 - $11.81 ($10.79) | $ 3.17 | -71% | Sold Out | 0 | ||
| ENZN | Richard Perry | 2011-06-30 | Reduce | -0.31% | $9.97 - $11.81 ($10.79) | $ 3.17 | -71% | Reduce -30.35% | 2,013,000 | |
| ENZN | Michael Price | 2011-03-31 | Add | 0.16% | $10.14 - $12.48 ($11.15) | $ 3.17 | -72% | Add 16.65% | 700,000 | |
| ENZN | George Soros | 2011-03-31 | Reduce | $10.14 - $12.48 ($11.15) | $ 3.17 | -72% | Reduce -52.5% | 30,400 | ||
| ENZN | Carl Icahn | 2010-12-31 | Add | 0.41% | $10.5 - $12.5 ($11.36) | $ 3.17 | -72% | Add 67.7% | 4,723,891 | |
| ENZN | Seth Klarman | 2010-09-30 | Add | 0.14% | $10.25 - $11.28 ($10.74) | $ 3.17 | -70% | Add 2.03% | 10,382,698 | |
| ENZN | George Soros | 2010-09-30 | Add | 0.01% | $10.25 - $11.28 ($10.74) | $ 3.17 | -70% | Add 481.74% | 66,900 | |
| ENZN | Seth Klarman | 2010-06-30 | Add | 0.78% | $10.07 - $11.45 ($10.67) | $ 3.17 | -70% | Add 10.57% | 10,175,898 | |
| ENZN | Richard Perry | 2010-06-30 | Add | 0.63% | $10.07 - $11.45 ($10.67) | $ 3.17 | -70% | Add 285.39% | 2,880,000 | |
| ENZN | George Soros | 2010-06-30 | Buy | $10.07 - $11.45 ($10.67) | $ 3.17 | -70% | New holding, 11500 sh. | 11,500 | ||
| ENZN | Seth Klarman | 2010-03-31 | Add | 0.7% | $9 - $11.28 ($9.99) | $ 3.17 | -68% | Add 13.87% | 9,203,100 | |
| ENZN | Michael Price | 2010-03-31 | Add | 0.64% | $9 - $11.28 ($9.99) | $ 3.17 | -68% | Add 137.9% | 530,000 | |
| | ||||||||||
| Ticker | Guru Name | Portfolio Date* | Current Shares | % of Shares Outstanding | % of Total Assets Managed | Change from Last Holdings | Holding History |
|---|---|---|---|---|---|---|---|
| ENZN | Charles Brandes | 2013-03-31 | 360,865 | 0.83 | 0.02 | +432.17% | |
| ENZN | Michael Price | 2013-03-31 | 748,800 | 1.71 | 0.37 | ||
| ENZN | Carl Icahn | 2013-03-31 | 5,904,863 | 13.51 | 0.13 | ||
| ENZN | Seth Klarman | 2013-03-31 | 7,691,453 | 17.6 | 0.94 | -2.02% |
Most recent portfolio changes are included for Premium Members only!ENZN: Insider Buys/Sells |
| Insider | Position | Date | Trades | Shares | Trade Price ($) | Change (%) | Details |
|---|---|---|---|---|---|---|---|
| LEBUHN ROBERT | Director | 2012-08-14 | Sell | 5,820 | $6.58 | -51.82 | view |
| LEBUHN ROBERT | Director | 2012-08-10 | Sell | 1,933 | $6.58 | -51.82 | view |
| HEBARD GEORGE | Interim PEO and Interim COO | 2012-06-20 | Buy | 5,000 | $6.88 | -53.92 | view |
| Rackear Andrew D. | VP and General Counsel | 2012-06-05 | Sell | 1,614 | $6.81 | -53.45 | view |
| Conover Charles | SVP, R&D Program Management | 2012-06-05 | Sell | 25,000 | $6.78 | -53.24 | view |
| Young Richard A | Director | 2012-03-15 | Sell | 2,000 | $6.92 | -54.19 | view |
| Rackear Andrew D. | VP and General Counsel | 2011-11-10 | Sell | 3,766 | $6.68 | -52.54 | view |
| Buchbinder Aby | VP, Clinical Development | 2011-11-08 | Sell | 2,700 | $7.06 | -55.1 | view |
| LEBUHN ROBERT | Director | 2011-06-01 | Sell | 8,702 | $10.57 | -70.01 | view |
| Ogden Mark L | Acting VP of Fin & Prin FO | 2011-02-28 | Buy | 2,000 | $10.65 | -70.23 | view |
Add Notes, Comments or Ask Questions
Comments